Kang Fang Selected Research

teroxirone (Tepic)

8/2018	Teroxirone motivates apoptotic death in tumorspheres of human lung cancer cells.
3/2018	Teroxirone suppresses growth and motility of human hepatocellular carcinoma cells.
9/2017	Reactive oxygen species-driven mitochondrial injury induces apoptosis by teroxirone in human non-small cell lung cancer cells.
11/2013	Teroxirone inhibited growth of human non-small cell lung cancer cells by activating p53.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kang Fang Research Topics

Disease

27	Neoplasms (Cancer) 04/2022 - 12/2002
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 12/2002
10	Lung Neoplasms (Lung Cancer) 08/2018 - 09/2010
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2018
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
2	Carcinogenesis 01/2021 - 01/2016
2	Liver Neoplasms (Liver Cancer) 01/2016 - 01/2012
1	Hypoxia (Hypoxemia) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Adenocarcinoma 01/2021
1	Esophageal Squamous Cell Carcinoma 01/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2018
1	Rupture 11/2018
1	Wounds and Injuries (Trauma) 03/2018
1	Neuroblastoma 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 04/2014
1	Starvation 05/2013
1	Carcinoma (Carcinomatosis) 01/2012

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 09/2018 - 12/2002
4	teroxirone (Tepic)IBA 08/2018 - 11/2013
4	ellipticineIBA 10/2016 - 01/2009
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2012
3	Antineoplastic Agents (Antineoplastics)IBA 09/2018 - 06/2017
3	Cisplatin (Platino)FDA LinkGeneric 09/2018 - 01/2007
3	3- ((7- ethyl- 1H- indol- 3- yl)- methyl)- 2- methylquinolineIBA 10/2017 - 11/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 04/2014
2	IronIBA 01/2022 - 01/2022
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 12/2002
2	ProdrugsIBA 01/2022 - 12/2002
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2018
2	tetramethylpyrazineIBA 11/2018 - 08/2018
2	Biological ProductsIBA 08/2018 - 06/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 09/2017
2	TriazolesIBA 01/2018 - 01/2016
2	Caspase 3 (Caspase-3)IBA 01/2018 - 12/2002
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 08/2002
2	Topoisomerase II InhibitorsIBA 09/2015 - 06/2005
1	N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP)IBA 04/2022
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2022
1	iniparibIBA 01/2022
1	Cystine (L-Cystine)IBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	InterferonsIBA 01/2022
1	IonsIBA 01/2022
1	ManganeseIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Pregnenolone Carbonitrile (PCN)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Hydroxyl RadicalIBA 01/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Metal-Organic FrameworksIBA 01/2022
1	polydopamineIBA 01/2022
1	Circular RNAIBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	QuassinsIBA 01/2021
1	Serum-Free Culture MediaIBA 01/2021
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2021
1	SuspensionsIBA 01/2021
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Ether (Diethyl Ether)IBA 11/2018
1	EstersIBA 11/2018
1	AldehydesIBA 11/2018
1	FlavonoidsIBA 08/2018
1	GelatinIBA 03/2018
1	Growth InhibitorsIBA 01/2018
1	TriterpenesIBA 06/2017
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 06/2017
1	Glycyrrhetinic Acid (Po 12)IBA 06/2017
1	Betulinic AcidIBA 06/2017
1	Oleanolic AcidIBA 06/2017
1	polyglutamineIBA 01/2016
1	indoleIBA 11/2015
1	quinolineIBA 11/2015
1	Topoisomerase InhibitorsIBA 09/2015
1	Carboplatin (JM8)FDA LinkGeneric 04/2014
1	CurcuminIBA 04/2014
1	Epoxy Compounds (Epoxides)IBA 11/2013
1	SaltsIBA 05/2013
1	SolutionsIBA 05/2013
1	Metalloproteases (Metalloproteinases)IBA 01/2012
1	goniothalaminIBA 04/2011
1	DNA (Deoxyribonucleic Acid)IBA 04/2011
1	Mitogen-Activated Protein KinasesIBA 09/2010
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2010

Therapy/Procedure

8	Therapeutics 01/2022 - 09/2015
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2022
1	Pancreaticoduodenectomy 04/2022
1	Pancreatectomy 04/2022
1	Immunomodulation 01/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2022
1	Photothermal Therapy 01/2022
1	Oral Administration 11/2018